Comments
Glenmark has received final approval from the US health regulator for its generic Mupirocin ointment used for the treatment of bacterial skin infections.
Glenmark Generics Inc, the US subsidiary of Glenmark Generics, has been granted a final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (USFDA) for Mupirocin ointment USP 2 per cent, the company said in a statement.
“Based on IMS health data for the 12-month period ending March 2011, Mupirocin ointment garnered annual sales of $55 million and achieved a 9 per cent increase in growth compared to the same period last year,” it said.
The ointment is used for the treatment of impetigo, a bacterial skin infection, and is available in a 22-gram tube.
The company’s current portfolio consists of 68 products authorised for distribution in the American market. It has 39 ANDAs pending approval.
Meanwhile, the shares of Glenmark Pharmaceuticals were being quoted at Rs 313.40 apiece in the late morning trade on the Bombay Stock Exchange today, up 1.56 per cent from the previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.